Form 4 for LIVN LivaNova PLC
Accepted 2026-08-13 16:04:10 ET · period of report 2026-08-11 · accession 0001639691-26-000094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-13 16:04 | 2026-08-11 | LIVN | Tezel Ahmet | Chief Innovation Off | M - OptEx | $52.68 | +12.7K | 18.8K | +208% | +$668.6K |
| D | 2026-08-13 16:04 | 2026-08-11 | LIVN | Tezel Ahmet | Chief Innovation Off | D - Sale to Iss | $77.86 | -8,589 | 10.2K | -46% | -$668.7K |
| D | 2026-08-13 16:04 | 2026-08-11 | LIVN | Tezel Ahmet | Chief Innovation Off | F - Tax | $77.86 | -1,428 | 8,765 | -14% | -$111.2K |
| D | 2026-08-13 16:04 | 2026-08-11 | LIVN | Tezel Ahmet | Chief Innovation Off | S - Sale+OE | $77.74 | -2,675 | 6,090 | -31% | -$207.9K |
| D | 2026-08-13 16:04 | 2026-08-11 | LIVN | Tezel Ahmet | Chief Innovation Off | M - OptEx | $0.00 | -12.7K | 12.7K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-08-11 | M | A | 12,692 | $52.68 | 18,782 | D | — | — | |
| 2 | Common | Ordinary Shares | 2026-08-11 | D | D | 8,589 | $77.86 | 10,193 | D | — | — | (F1) Shares withheld in payment of the base price in connection with the exercise of stock appreciation rights (SARs). |
| 3 | Common | Ordinary Shares | 2026-08-11 | F | D | 1,428 | $77.86 | 8,765 | D | — | — | (F2) Shares withheld to satisfy tax liability. |
| 4 | Common | Ordinary Shares | 2026-08-11 | S | D | 2,675 | $77.74 | 6,090 | D | — | — | (F3) The shares were sold in multiple open-market transactions at prices from $77.6684 to $77.7900; the reported price reflects the weighted-average sale price. The reporting person undertakes to provide to LivaNova PLC (the Company), any security holder of the Company, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Appreciation Rights | 2026-08-11 | M | D | 12,692 | $0.00 | 12,691 | D | $52.68 · — to 2034-06-15 | 12,692 Ordinary Shares | (F4) The SARs were granted on June 15, 2024, vesting in four equal annual installments beginning June 15, 2025, and are subject to forfeiture prior to vesting under the terms of the Amended and Restated LivaNova PLC 2022 Incentive Award Plan and the award agreement. |